Paul Dagg

Program: Neuropsychiatry

 

Contact info

Hillside Centre
311 Columbia
Kamloops, V2C 2T1
2503142388

Professional Affiliations and other Positions

American College of Psychiatry, Member 2011
Program Medical Director, Mental health and Substance Use Program, Interior Health Authority
 

Research and Interests

Program Page: Neuropsychiatry

 

Biography

Paul Dagg is currently the Program Medical Director for the Mental Health and Substance Use Program for the Interior Health Authority of British Columbia.  He moved to BC in 2005 to establish the Tertiary Mental Health Services for the Interior that were being developed as a result of the regionalization of services from the Riverview Hospital, opening Hillside Centre in Kamloops, and leading Tertiary Mental Health Services until 2016.  He provides psychiatric and neuropsychiatric care for people with refractory illness who are admitted to Hillside Centre, a tertiary acute inpatient facility that provides services to clients from throughout the province. He is a Clinical Professor in the Department of Psychiatry at UBC and in 2013 was inducted as a member of the American College of Psychiatry.                                                    

Dr. Dagg has been heavily involved in postgraduate training in medicine and psychiatry and in 2016 was awarded the Duncan Graham Award for lifelong contribution to medical education in Canada by the Royal College of Physicians and Surgeons of Canada. He is currently Chair of the Corporate Accreditation Committee of the Royal College and a Member of the Education Committee of the Royal College, the committee that oversees all the educational activities of the College.  Until 2005, he was the Assistant Dean for Postgraduate Education in the Faculty of Medicine at the University of Ottawa, and Associate Professor and Vice Chair in the Department of Psychiatry.

 

Selected Publications

M.Morrow, P. Dagg, A. Pederson.  Is Deinstitutionalization a “failed experiment”?  The ethics of reinstitutionalization,  Journal of Ethics in Mental Health, 3:2, November, 2008.

C. Wu, P. Dagg, C. Molgat.  A pilot study to measure cognitive impairment in patients with severe schizophrenia with the Montreal Cognitive Assessment (MoCA).  Schizophrenia Research, 158 (151-155), 2014.

C. Wu, P. Dagg, C. Ward, M. Crawford.  The Inhibition of Return is Not More Deficient in Older Adults with Schizophrenia.  The International Journal of Aging in Society, 1:4, 49-59, 2012

P. Dagg.  Guidelines for Sedating Psychiatric Patients Flawed.  British Columbia Medical Journal, 52:1, 20-21, 2010.

P. Dagg.  The psychological sequelae of therapeutic abortion – denied and completed.  American Journal of Psychiatry, 148:5, May 1991.

Program members: